CN

CRISPR & Gene Editing

CRISPR/Cas9 is a targeted genome editing tool, first discovered in bacteria, containing two components – a guide RNA (gRNA) and a Cas9 nuclease.

CRISPR/Cas9 is a targeted genome editing tool, first discovered in bacteria, containing two components – a guide RNA (gRNA) and a Cas9 nuclease. This versatile system enables researchers to produce targeted gene modifications, including gene knockouts, large integrations, point mutations, and gene tagging in cell lines, animal models, plants, and bacteria. CRISPR/Cas9 can also function in a nuclease-independent manner that inhibits (CRISPRi) or activates (CRISPRa) gene expression for further genetic pathway interrogation.

The low cost and ease-of-use of CRISPR mean it is now easier than ever to utilize in individual experiments or at whole-genome scale for screening applications.

CompoZr® Zinc Finger Nucleases (ZFNs) are a class of engineered DNA-binding proteins that facilitate targeted editing of the genome by creating double-strand breaks using the Fok1 endonuclease. ZFNs have high on-target specificity, making them excellent tools for pre-clinical and clinical therapeutic development. For large targeted integrations, ZFNs often display higher efficiency than other gene editing tools.

With decades of gene editing experience and numerous global patents for CRISPR technology, the Sigma-Aldrich® portfolio provides high quality reagents for your entire workflow, so you can edit with confidence. Take your research Beyond the Bench with the comprehensive Sigma-Aldrich® suite of CRISPR and ZFN gene-editing tools and services.



社交媒体

WeChat Icon
Bilibili Icon

默克

研究、开发、生产

作为生命科学行业的全球领先供应商,我们致力于为研究、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. 保留所有权利。

严格禁止在未经同意的情况下转载本网站之所有信息。 Sigma-Aldrich品牌产品均由Sigma-Aldrich LLC.独家贩售。